Skip to main content

Table 1 Baseline characteristics of study patients

From: High sensitivity troponin T and I reflect mitral annular plane systolic excursion being assessed by cardiac magnetic resonance imaging

Characteristic Patients
(n = 84)
Age, mean (range; 95% CI) 55 (18–85; 52–59)
Gender, n (%)
 Male 58 (69)
 Female 26 (31)
Cardiovascular risk factors, n (%)
 Arterial hypertension 37 (44)
 Hypercholesterinemia 21 (25)
 Cardiac family history 15 (18)
 Smoking status 32 (38)
 Diabetes mellitus 11 (13)
 Adipositas 12 (14)
Laboratory parameters, median (IQR)
 Creatinine (mg/dL) 0.89 (0.78–1.04)
 GFR (mL/min) 89 (75–101)
Prior medical history, n (%)
 Chronic heart failure 26 (31)
  NYHA I 10 (38)
  NYHA II 14 (54)
  NYHA III 2 (8)
  NYHA IV 0 (0)
 Atrial fibrillation 13 (15)
  Paroxysmal 8 (10)
  Persistent 3 (4)
  Permanent 2 (2)
 Coronary artery disease 26 (31)
  1 vessel disease 10 (12)
  2 vessel disease 3 (4)
  3 vessel disease 13 (15)
 Past history of myocardial infarction 17 (20)
 Valvular heart disease 31 (37)
 Chronic kidney disease 7 (8)
 COPD 7 (8)
 Asthma 6 (7)
 Pneumonia 2 (2)
 Pulmonary hypertension 1 (1)
 Cancer 7 (8)
Medication, n (%)
 ACE-inhibitor/AT1-receptor antagonist 43 (51)
 Beta blocker 43 (51)
 Aldosterone antagonist 15 (18)
 Calcium antagonist 18 (21)
 Diuretics 45 (54)
 Acetylsalicylic acid 32 (38)
 Thienopyridines 9 (11)
 OAC/NOAC 14 (17)
 Statin 34 (40)
  1. ACE angiotensin converting enzyme, AT1 angiotensin 1, OAC oral anticoagulant, NOAC novel oral anticoagulant, CI confidence interval, IQR interquartile range